CUPRIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cupric, and what generic alternatives are available?
Cupric is a drug marketed by Amneal, Exela Pharma, Somerset, Stira, Hospira, Abraxis Pharm, Am Regent, and Apotex Corp. and is included in eight NDAs.
The generic ingredient in CUPRIC is cupric sulfate. Additional details are available on the cupric sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cupric
A generic version of CUPRIC was approved as cupric sulfate by AM REGENT on December 16th, 2022.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CUPRIC?
- What are the global sales for CUPRIC?
- What is Average Wholesale Price for CUPRIC?
Summary for CUPRIC
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| DailyMed Link: | CUPRIC at DailyMed |
US Patents and Regulatory Information for CUPRIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | CUPRIC CHLORIDE | cupric chloride | INJECTABLE;INJECTION | 217287-001 | Jan 26, 2026 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Am Regent | CUPRIC SULFATE | cupric sulfate | INJECTABLE;INJECTION | 216324-001 | Dec 16, 2022 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Stira | CUPRIC CHLORIDE | cupric chloride | INJECTABLE;INJECTION | 217626-001 | Apr 30, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Apotex Corp | CUPRIC SULFATE | cupric sulfate | INJECTABLE;INJECTION | 218745-001 | Aug 19, 2024 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Exela Pharma | CUPRIC CHLORIDE | cupric chloride | INJECTABLE;INJECTION | 212071-001 | Oct 31, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Somerset | CUPRIC CHLORIDE | cupric chloride | INJECTABLE;INJECTION | 216113-001 | Apr 30, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Abraxis Pharm | CUPRIC SULFATE | cupric sulfate | INJECTABLE;INJECTION | 019350-001 | May 5, 1987 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
